1/13
Vocabulary flashcards covering the key terms, definitions, diagnostic tests, clinical manifestations, and management of Myasthenia Gravis based on lecture material.
Myasthenia Gravis
A chronic autoimmune neuromuscular disease meaning "grave muscle weakness," characterized by muscle weakness that increases with activity and improves after periods of rest due to disruption of acetylcholine transmission.
Acetylcholine (ACh)
The neurotransmitter responsible for transmitting signals between axonal terminals and receptor sites of voluntary muscles, which is targeted and blocked in Myasthenia Gravis.
IgG Antibodies
Acetylcholine receptor antibodies responsible for the etiology of Myasthenia Gravis by blocking ACh receptor sites, accelerating ACh breakdown, and destroying receptor sites.
Ptosis
The drooping of one or both eyelids, representing a classic hallmark facial muscle weakness in Myasthenia Gravis.
Diplopia
Double vision, a common symptom in Myasthenia Gravis caused by weakness in the voluntary muscles that control eye movement.
Dysphagia
Difficulty in swallowing, resulting from muscle weakness in the face, throat, and voluntary muscles.
Edrophonium Test
Also known as the Tensilon Challenge, a test used to diagnose Myasthenia Gravis and monitor therapy by evaluating muscle strength response after administering edrophonium.
Myasthenic Crisis
A state of acute muscle weakness that improves following edrophonium (Tensilon) administration, indicating that more anticholinesterase drug therapy is needed.
Cholinergic Crisis
A state of severe muscle weakness that worsens following edrophonium (Tensilon) administration, indicating an overdose of anticholinesterase medication.
Atropine
A medication administered to reverse edrophonium (Tensilon) and relieve symptoms associated with a cholinergic crisis.
Ice Pack Test
A diagnostic test for Myasthenia Gravis involving the application of an ice pack to a droopy eyelid for 5min, after which improvement in ptosis is evaluated.
Indicators of Acute Ventilatory Failure
Clinical threshold criteria in Myasthenia Gravis signaling impending or acute ventilatory failure: VC<20mL/kg, NIF<−30cmH2O, pH<7.35, or PaCO2>45mmHg.
Anatomic Alterations of the Lungs
Pulmonary conditions associated with unmanaged ventilatory failure in Myasthenia Gravis, including mucus accumulation, airway obstruction, alveolar consolidation, and atelectasis.
Thymectomy
A surgical procedure involving the removal of the thymus gland, used in the management of Myasthenia Gravis to stop disease progression.